Idun
Pharmaceuticals, Inc. |
Idun
Pharmaceuticals creates innovative human therapeutics with a primary focus on
controlling apoptosis, or programmed cell death. Idun's focus is on small molecule
therapeutics that act to either inhibit or stimulate apoptosis. In its drug discovery
programs, Idun is targeting proteins that have been shown genetically and functionally to
be key control points in the apoptosis pathway.
Idun has a broad patent portfolio, including 36 issued patents, covering many of the key
genes involved in the regulation of apoptosis. |
July 99 Idun Pharmaceuticals initiates
plant apoptosis protection program (2029)
. |
11085 North Torrey Pines Road, Suite 300
· La Jolla, California 92037 · Tel: +1 619-623-1330 |
|